Qiagen (NYSE:QGEN) Receives Consensus Rating of “Hold” from Brokerages

Shares of Qiagen (NYSE:QGEN) have been given a consensus rating of “Hold” by the ten brokerages that are covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $48.42.

QGEN has been the subject of a number of research analyst reports. UBS Group lowered their price objective on shares of Qiagen from $50.00 to $48.00 and set a “neutral” rating for the company in a research report on Friday, February 7th. Redburn Atlantic cut shares of Qiagen from a “buy” rating to a “neutral” rating in a research note on Friday, April 4th. StockNews.com upgraded Qiagen from a “buy” rating to a “strong-buy” rating in a research note on Thursday. Baird R W downgraded Qiagen from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 19th. Finally, Robert W. Baird boosted their price objective on Qiagen from $42.00 to $43.00 and gave the stock a “neutral” rating in a research report on Monday, April 21st.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Geneos Wealth Management Inc. raised its position in shares of Qiagen by 41.5% during the fourth quarter. Geneos Wealth Management Inc. now owns 856 shares of the company’s stock worth $38,000 after acquiring an additional 251 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its position in Qiagen by 3.6% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 9,816 shares of the company’s stock valued at $438,000 after purchasing an additional 341 shares during the period. Pitcairn Co. raised its holdings in Qiagen by 5.3% during the 4th quarter. Pitcairn Co. now owns 6,996 shares of the company’s stock worth $312,000 after purchasing an additional 354 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in shares of Qiagen by 2.3% in the 1st quarter. Exchange Traded Concepts LLC now owns 17,825 shares of the company’s stock worth $716,000 after purchasing an additional 395 shares during the period. Finally, Headlands Technologies LLC boosted its stake in shares of Qiagen by 2.0% in the 4th quarter. Headlands Technologies LLC now owns 19,823 shares of the company’s stock valued at $883,000 after purchasing an additional 397 shares during the last quarter. 70.00% of the stock is owned by institutional investors and hedge funds.

Qiagen Stock Performance

Shares of NYSE:QGEN opened at $42.65 on Wednesday. Qiagen has a 1 year low of $37.63 and a 1 year high of $49.30. The stock has a market capitalization of $9.48 billion, a price-to-earnings ratio of 118.76, a price-to-earnings-growth ratio of 2.39 and a beta of 0.67. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.61 and a quick ratio of 3.09. The company’s 50 day simple moving average is $40.97 and its 200 day simple moving average is $41.81.

Qiagen (NYSE:QGEN) last issued its earnings results on Wednesday, May 7th. The company reported $0.55 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.05. Qiagen had a return on equity of 13.92% and a net margin of 4.23%. The firm had revenue of $483.46 million for the quarter, compared to the consensus estimate of $465.66 million. During the same quarter last year, the business posted $0.44 EPS. The company’s revenue was up 5.2% compared to the same quarter last year. As a group, research analysts predict that Qiagen will post 2.26 EPS for the current fiscal year.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.